-
961por Rahier, Jean-François, Moutschen, Michel, Van Gompel, Alfons, Van Ranst, Marc, Louis, Edouard, Segaert, Siegfried, Masson, Pierre, De Keyser, Filip“…Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for hepatitis B, influenza and pneumococcal vaccination. Vaccination status is best checked and updated before the start of immunomodulatory therapy: live vaccines are not contraindicated at that time and inactivated vaccines elicit an optimal immune response in immunocompetent individuals.…”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
962Recombinant Plants Provide a New Approach to the Production of Bacterial Polysaccharide for Vaccinespor Smith, Claire M., Fry, Stephen C., Gough, Kevin C., Patel, Alexandra J. F., Glenn, Sarah, Goldrick, Marie, Roberts, Ian S., Whitelam, Garry C., Andrew, Peter W.“…Because it is used a component of anti-pneumococcal vaccines, the immunogenicity of the plant-derived type 3 polysaccharide was tested. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
963por Ballegaard, Vibe C, Schejbel, Lone, Hoffmann, Steen, Kantsø, Bjørn, Fischer, Christian P“…To our knowledge, there has been no previously reported case of recurrent invasive pneumococcal disease in a pneumococcal vaccinated adult with hyposplenia and apparently sufficient antibody response. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
964“…CONCLUSION: The low-level variation described provides evidence for the stability of the experimental human pneumococcal carriage model over 35 days, which can be reliably and confidently used to measure VEcol and aid future progression of pneumococcal vaccination.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
965por Murdaca, Giuseppe, Noberasco, Giovanni, Battaglini, Alberto, Vassallo, Chiara, Giusti, Francesca, Greco, Monica, Schiavi, Chiara, Sticchi, Laura, Icardi, Giancarlo, Orsi, Andrea“…We evaluated the influenza and pneumococcal vaccination rate among various subgroups of patients and the source of the recommendation for vaccination. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
966por Loiacono, Matthew M., Mitsakakis, Nicholas, Kwong, Jeffrey C., Gomez, Gabriela B., Chit, Ayman, Grootendorst, Paul“…Prior season SIV uptake and pneumococcal vaccination status were the best predictors of SIV uptake. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
967por Ghaswalla, Parinaz, Bengtson, Lindsay, Marshall, Gary S, Buikema, Ami R, Bancroft, Tim, Schladweiler, Krista, Koep, Eleena, Novy, Patricia, Hogea, Cosmina“…A strong association between receipt of MenACWY and pneumococcal vaccines was seen for CD [hazard ratio (HR): 3.2; 95% CI: 1.8–5.7] and HIV [23.0; 13.9–38.1]. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
968por Seo, Philip, Winthrop, Kevin, Sawalha, Amr Hakam, Choi, Serim, Hwang, Woochang, Park, Hyun Ah, Lee, Eun Bong, Park, Jin Kyun“…There was a high level of agreement with the recommendations regarding influenza and pneumococcal vaccinations; implementation of these recommendations was also high. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
969“…We report a case of a 65-year-old Caucasian female with a past medical history of obesity who developed excessive daytime sleepiness, fatigue, and sleep attacks five weeks after getting influenza and pneumococcal vaccines. The presentation of cataplexy was atypical. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
970por Robertson, J D, Nagesh, K, Jowitt, S N, Dougal, M, Anderson, H, Mutton, K, Zambon, M, Scarffe, J H“…These results question the practice of routine influenza and pneumococcal vaccination in myeloma patients. © 2000 Cancer Research Campaign…”
Publicado 2000
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
971“…Preterm born infants should receive pneumococcal vaccination according to their chronological age.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
972por Kimaro Mlacha, Sheila Z, Romero-Steiner, Sandra, Dunning Hotopp, Julie C, Kumar, Nikhil, Ishmael, Nadeeza, Riley, David R, Farooq, Umar, Creasy, Todd H, Tallon, Luke J, Liu, Xinyue, Goldsmith, Cynthia S, Sampson, Jacquelyn, Carlone, George M, Hollingshead, Susan K, Scott, J Anthony G, Tettelin, Hervé“…BACKGROUND: Streptococcus pneumoniae is a leading cause of childhood morbidity and mortality worldwide, despite the availability of effective pneumococcal vaccines. Understanding the molecular interactions between the bacterium and the host will contribute to the control and prevention of pneumococcal disease. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
973“…He received pneumococcal vaccination two years ago. On examination during this admission, he was found to be febrile (104.3 F) and confused and had a grade 2/6 systolic murmur at the apex without any radiation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
974por Ramdani-Bouguessa, N., Ziane, H., Bekhoucha, S., Guechi, Z., Azzam, A., Touati, D., Naim, M., Azrou, S., Hamidi, M., Mertani, A., Laraba, A., Annane, T., Kermani, S., Tazir, M.“…Our results highlight the burden of pneumococcal disease in Algeria and the increasing S. pneumoniae antibiotic resistance. The current pneumococcal vaccines cover a high percentage of the circulating strains. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
975por Chochua, Sopio, Metcalf, Benjamin J., Li, Zhongya, Walker, Hollis, Tran, Theresa, McGee, Lesley, Beall, Bernard“…Protection against serotype 35B should be considered in next-generation pneumococcal vaccines.…”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
976por Kurbatova, Ekaterina A., Akhmatova, Nelli K., Akhmatova, Elina A., Egorova, Nadezhda B., Yastrebova, Natalya E., Sukhova, Elena V., Yashunsky, Dmitriy V., Tsvetkov, Yury E., Gening, Marina L., Nifantiev, Nikolay E.“…Identifying protective synthetic oligosaccharide (OS) epitopes of Streptococcus pneumoniae capsular polysaccharides (CPs) is an indispensable step in the development of third-generation carbohydrate pneumococcal vaccines. Synthetic tetra-, hexa-, and octasaccharide structurally related to CP of S. pneumoniae type 14 were coupled to bovine serum albumin (BSA), adjuvanted with aluminum hydroxide, and tested for their immunogenicity in mice upon intraperitoneal prime-boost immunizations. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
977por Cohen, Aviad, Troib, Shani, Dotan, Shahar, Najmuldeen, Hastyar, Yesilkaya, Hasan, Kushnir, Tatyana, Shagan, Marilou, Portnoi, Maxim, Nachmani, Hannie, Benisty, Rachel, Tal, Michael, Ellis, Ronald, Chalifa-Caspi, Vered, Dagan, Ron, Nebenzahl, Yaffa Mizrachi“…Taken together, the ability of rTF to elicit a protective immune response, involvement of TF in bacterial adhesion, conservation of the protein among pneumococcal strains and the lack of human homologue, all suggest that rTF can be considered as a future candidate vaccine with a much broader coverage as compared to the currently available pneumococcal vaccines.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
978“…Among individuals with DM, female sex, DM complications, smokers and administration of pneumococcal vaccines were significant factors associated with a pneumonia event.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
979“…Ninety-three percent of responders were aware that influenza vaccine should be administered annually, and 94% acknowledged the need for pneumococcal vaccination. Some were not concerned about reduced immunogenicity in patients receiving treatment with methotrexate/TNF inhibitors and rituximab/abatacept (17% and 7%, respectively). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
980por Afshar, Davoud, Moghadam, Solmaz Ohadian, Dehkordi, Farhad Safarpoor, Ranjbar, Reza, Hasanzadeh, Amir“…We aimed to investigate immunodominant antigens in S. pneumoniae culture supernatant in order to develop novel targets for pneumococcal vaccines. MATERIALS AND METHODS: In this study S. pneumoniae ATCC49619 was sub-cultured into BHI broth from overnight culture at 37°C for 4 h. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto